These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27772757)

  • 1. Recombinant tissue plasminogen activator enhances microparticle release from mouse brain-derived endothelial cells through plasmin.
    Garraud M; Khacef K; Vion AC; Leconte C; Yin M; Renard JM; Marchand-Leroux C; Boulanger CM; Margaill I; Beray-Berthat V
    J Neurol Sci; 2016 Nov; 370():187-195. PubMed ID: 27772757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
    Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced poly(ADP-ribose) polymerase-1 activation contributes to recombinant tissue plasminogen activator-induced aggravation of ischemic brain injury in vivo.
    Crome O; Doeppner TR; Schwarting S; Müller B; Bähr M; Weise J
    J Neurosci Res; 2007 Jun; 85(8):1734-43. PubMed ID: 17455321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
    Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
    J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Reperfusion and Vasculoprotection by the Poly(ADP-Ribose)Polymerase Inhibitor PJ34 After Stroke and Thrombolysis in Mice.
    El Amki M; Lerouet D; Garraud M; Teng F; Beray-Berthat V; Coqueran B; Barsacq B; Abbou C; Palmier B; Marchand-Leroux C; Margaill I
    Mol Neurobiol; 2018 Dec; 55(12):9156-9168. PubMed ID: 29651748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin.
    Niego B; Lee N; Larsson P; De Silva TM; Au AE; McCutcheon F; Medcalf RL
    PLoS One; 2017; 12(5):e0177332. PubMed ID: 28510599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles.
    Curtis AM; Wilkinson PF; Gui M; Gales TL; Hu E; Edelberg JM
    J Thromb Haemost; 2009 Apr; 7(4):701-9. PubMed ID: 19192109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of common housekeeping proteins under ischemic conditions and/or rt-PA treatment in bEnd.3 cells.
    Comajoan P; Gubern C; Huguet G; Serena J; Kádár E; Castellanos M
    J Proteomics; 2018 Jul; 184():10-15. PubMed ID: 29929036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro.
    Lacroix R; Sabatier F; Mialhe A; Basire A; Pannell R; Borghi H; Robert S; Lamy E; Plawinski L; Camoin-Jau L; Gurewich V; Angles-Cano E; Dignat-George F
    Blood; 2007 Oct; 110(7):2432-9. PubMed ID: 17606760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
    Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
    Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel effectively suppresses endothelial microparticle generation induced by indoxyl sulfate via inhibition of the p38 mitogen-activated protein kinase pathway.
    Ryu JH; Kim SJ
    Blood Purif; 2011; 32(3):186-94. PubMed ID: 21811066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial microparticles are increased in congenital heart diseases and contribute to endothelial dysfunction.
    Lin ZB; Ci HB; Li Y; Cheng TP; Liu DH; Wang YS; Xu J; Yuan HX; Li HM; Chen J; Zhou L; Wang ZP; Zhang X; Ou ZJ; Ou JS
    J Transl Med; 2017 Jan; 15(1):4. PubMed ID: 28049487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tissue-type plasminogen activator in ischemic stroke.
    Suzuki Y
    J Pharmacol Sci; 2010; 113(3):203-7. PubMed ID: 20595786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin.
    Kwaan HC; Wang J; Weiss I
    J Thromb Haemost; 2004 Feb; 2(2):306-12. PubMed ID: 14995994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
    Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-Phe-Pro-Arg-chloromethylketone: its potential use in inhibiting the formation of in vitro artifacts in blood collected during tissue-type plasminogen activator thrombolytic therapy.
    Mohler MA; Refino CJ; Chen SA; Chen AB; Hotchkiss AJ
    Thromb Haemost; 1986 Oct; 56(2):160-4. PubMed ID: 2433785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asymmetric dimethylarginine impairs fibrinolytic activity in human umbilical vein endothelial cells via p38 MAPK and NF-κB pathways.
    Zhang Q; Chen N; Qiu W; Xu X; Wang D; Tsao PS; Jin H
    Thromb Res; 2011 Jul; 128(1):42-6. PubMed ID: 21429569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis.
    Lacroix R; Plawinski L; Robert S; Doeuvre L; Sabatier F; Martinez de Lizarrondo S; Mezzapesa A; Anfosso F; Leroyer AS; Poullin P; Jourde N; Njock MS; Boulanger CM; Anglés-Cano E; Dignat-George F
    Haematologica; 2012 Dec; 97(12):1864-72. PubMed ID: 22733025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.